Associations of circulating inflammatory biomarkers with risk factors for colorectal cancer in colorectal adenoma patients

Biomarker Insights

Volumn 7, Issue , 2012, Pages 143-150

  Hopkins, Myfanwy H ^a   Dana Flanders, W ^a   Bostick, Roberd M ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Biomarkers; Colonic neoplasms; Inflammation

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALCIUM INTAKE; CALORIC INTAKE; CANCER RISK; COLORECTAL ADENOMA; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; DRUG USE; FEMALE; GENDER; HUMAN; INFLAMMATION Z SCORE; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCORING SYSTEM; VITAMIN BLOOD LEVEL; WAIST HIP RATIO;

EID: 84869068978     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.4137/BMI.S10092     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-49.
2. Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132(6):2208-25.
3. Bertagnolli M. Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back. Lancet Oncol. 2007;8(5): 439-43.
4. Baron J, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med. 1999;340(2):101-7.
5. Wei M, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2958-69.
6. Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300(23): 2765-78.
7. Giovannucci E, Goldin B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am J Clin Nutr. 1997;66(6 Suppl): 1564S-71.
8. Groblewska MMB, Wereszczynska-Siemiatkowska U, Kedra B, Lukaszewicz M, Baniukiewicz A, Szmitkowski M. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin Chem Lab Med. 2008;46(10):1423-8.
9. Chung YC, Chang YF. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol. 2003;83(4):222-6.
10. Potter J. Colorectal cancer: molecules and populations. J Natl Cancer Inst. 1999;91(11):916-32.
11. Nikiteas NI, Tzanakis N, Gazouli M, et al. Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol. 2005;11(11):1639-43.
12. Szlosarek P, Balkwill FR. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 2003;4(9):565-73.
13. Heikkilä KES, Lawlor DA. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur J Cancer. 2008;44(7): 937-45.
14. Kim S, Keku TO, Martin C, et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Research. 2008;68(1):323-8.
15. Hopkins MH, Owen J, Ahearn T, et al. Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial. Cancer Prev Res (Phila). 2011;4(10): 1645-54.
16. Fedirko V, Bostick RM, Flanders WD, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res. 2009;2(3):213-23.
17. Kaminska J, Nowacki MP, Kowalska M, et al. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I-an independent prognostic factor. Tumour Biol. 2005;26(4):186-94.
18. Landi S, Moreno V, Gioia-Patricola L, et al; Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003;63(13):3560-6.
19. Gunter M, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1126-31.
20. Kaler P, Godasi BN, Augenlicht L, Klampfer L. The NF-kappaB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1beta. Cancer Microenviron. 2009;25:25.
21. Das UN. Is obesity an inflammatory condition? Nutrition. 2001;17(11-2): 953-66.
22. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282(22):2131-5.
23. Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis. 2006;186(1):113-20.
24. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem. 2004; 279(47):48487-90.